The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression – a proof-of-concept study

Journal of Pharmacy and Pharmacology

Volumn 69, Issue 4, 2017, Pages 417-431

  Orubu, Samuel E F ^a   Hobson, Nicholas J ^a   Basit, Abdul W ^a   Tuleu, Catherine ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

design of experiments; direct compression; milk based tablets

Indexed keywords

ARTICLE; ARTIFICIAL MILK; CHEMICAL COMPOSITION; CONTROLLED STUDY; CRUSHING STRENGTH; DISPERSIBLE TABLET; HAUSNER RATIO; MILK POWDER; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET POROSITY; TENSILE STRENGTH; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; COMPRESSIVE STRENGTH; DRUG FORMULATION; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; MILK; PROCEDURES; SOLUBILITY; TABLET;

TABLET;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; DRUG COMPOUNDING; HUMANS; MILK; SOLUBILITY; TABLETS; TENSILE STRENGTH;

EID: 84977567777     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12570     Document Type: Article

References (53)

1. Ivanovska V et al. Paediatric drug formulations: A review of challenges and progress. Pediatrics 2014; 134: 361.
2. Kozarewicz P. Regulatory perspectives on acceptability testing of dosage forms in children. Int J Pharm 2014; 469: 245–248.
3. Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol 2005; 59: 674–676.
4. Davies EH, Tuleu C. Medicines for children: a matter of taste. J Pediatr 2008; 153: 599–604.
5. WHO. Development of paediatric medicines: points to consider in pharmaceutical development. 2011. Available from http://www.who.int/medicines/areas/quality_safety/quality_assurance/Rev3-PaediatricMedicinesDevelopment_QAS08-257Rev3_17082011.pdf. Accessed 14 Dec 2011.
6. McDaniel MR et al. Sensory characterization of human milk. J Dairy Sci 1989; 72: 1149–1158.
7. Alves JGB et al. Facial responses to basic tastes in breastfeeding and formula-feeding infants. Breastfeed Med 2013; 8: 235–236.
8. Schwartz C et al. Breast-feeding duration: influence on taste acceptance over the first year of life. Bri J Nutr 2013; 109: 1154–1161.
9. Sousa SG et al. Human milk composition and preservation: Evaluation of high-pressure processing as a non-thermal pasteurisation technology. Crit Rev Food Sci Nutr 2016; 56: 1043–1060.
10. Watson Dairy Consulting. Milk powder production. 2015. www.dairyconsultant.co.uk/pdf/milk_powder_production.pdf. Accessed 16 Mar 2015.
11. FAO and WHO. Milk and milk products. 2nd edn. 2011. Available from http://www.fao.org/docrep/015/i2085e/i2085e00.pdf. Accessed 29 Oct 2012.
12. WHO. Complementary feeding. 2015. Available from http://www.who.int/nutrition/topics/complementary_feeding/en/. Accessed 30 Apr 2015.
13. The Caroline Walker Trust. Infant milk in the UK. 2011. Available from http://www.cwt.org.uk/pdfs/infantsmilk_web.pdf. Accessed 29 Oct 2012.
14. Charkoftaki G et al. Novel milk-based oral formulations: proof of concept. Int J Pharm 2010; 390: 150–159.
15. Macheras P, inventor; Pharmathen S.A, assignee. Pharmaceutical formulation containing lipophilic drugs and milk as a solubilizing/dispensing agent and method for the preparation thereof. United States patent application publication. US20130190252 A1. 2013 Jul 25.
16. Şahin NO, Arslan H. Inclusion complex of prednisolone with skimmed milk: Part I: physicochemical characterization. YakugakuZasshi 2007; 127: 1255–1261.
17. Bennett SM et al. Using milk fat to reduce the bitterness and irritation of Ibuprofen. Chemosens Percept 2012; 5: 231–236.
18. Shroppolo F et al. inventors. Pharmaceutical composition comprising skim milk powder. United States patent US 20050118258. 2005Jun 2.
19. Shibata M et al. inventors; Meiji Dairies Corporation, assignee. Solid milk and method for manufacturing thereof. United States patent US20080292770 A1. 2008 Nov 27.
20. Shibata M et al. Tabletting of powdered milk and the resulting physical properties. YakugaZasshi. 2011; 131: 1503–1507. Japanese.
21. Ndife LI et al. inventors; Abbott Laboratory, assignee. Infant formula. United States patent US7070825 B2. 2006 Jul 4.
22. Pinto J.T et al. 2015. Evaluation of the ability of powdered milk to produce mini-tablets delivery of paracetamol in paediatrics. Oral presentation. 7th International Granulation Workshop, University of Sheffield, UK. [Online]. Available from: http://www.shef.ac.uk/polopoly_fs/1.472578!/file/2015_abstract_list_granulation_workshop.pdf [Accessed 18 August 2015].
23. E Teunou et al. Characterisation of food powder flowability, J Food Eng 1999; 39 31–37, ISSN 0260-8774. Available from http://dx.doi.org/10.1016/S0260-8774(98)00140-X.
24. Liu LX et al. Effect of particle properties on the flowability of ibuprofen powders. Int J Pharm 2008; 362: 109–117.
25. Eriksson L et al. Design of experiments: principles and applications, 3rd edn. Umea: Umetrics Academy, 2008: 1–6.
26. DataPharm. Caffeine citrate 10 mg/ml Oral Solution. Summary of Product Characteristics. Available from https://www.medicines.org.uk/emc/medicine/28345. Assessed 25 Apr 2015.
27. Waitrose. Marvel Original dried skimmed milk powder. 2015. Available from http://www.waitrose.com/shop/ProductView-10317-10001-27217-Marvel+Original+dried+skimmed+milk+powder. Accessed 25 Apr 2015
28. Tesco. Nestle Nido Instant Full Cream Milk Powder. 2015. Available from http://www.tesco.com/groceries/Product/Details/?id=260148289. Accessed 25 Apr 2015
29. Boots. SMA Lactose Free from birth. 2015. Available from http://www.boots.com/en/SMA-Lactose-Free-from-Birth-430g_6986/. Accessed 25 Apr 2015
30. Eriksson L et al. Design of experiments: principles and applications, 3rd ed. Umea: Umetrics Academy; 2008. p 41, 231–238.
31. Eriksson L et al. Design of experiments: principles and applications, 3rd edn. Umea: Umetrics Academy; 2008. p. 77–78, 88
32. British Pharmacopoeia 2015 Volume V. Powder flow. London: The Stationery Office; 2014: 518–519.
33. British Pharmacopoeia 2015 Volume V. Consistency of Formulated Preparations. London: The Stationery Office; 2014: 371.
34. British Pharmacopoeia 2015 Volume V. Friability. London: The Stationery Office; 2014: 511.
35. British Pharmacopoeia 2015 Volume V. Resistance to Crushing of Tablets. London: Stationery Office; 2014: 513.
36. Fell JT, Newton JM. The tensile strength of tablets. J Pharm Pharmacol 1968; 20: 657–658.
37. British Pharmacopoeia 2015 Volume III. Dispersible Tablets. London: The Stationery Office; 2014: 75.
38. Rowe RC et al. Handbook of Pharmaceutical Excipients, 6th edn. London: Pharmaceutical Press and American Pharmacists Association, 2012.
39. Roquette. Direct compression solutions. Pearlitol SC and DC for high stability and versatility. Available from http://www.directcompression.roquettepharma.com/ (2015). Accessed 25 Apr 2015.
40. Li J, Wu Y. Lubricants in pharmaceutical solid dosage forms. Lubricants 2014; 2: 21–43.
41. Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs) – a novel solid oral dosage form for paediatric use. Euro J Pharm Biopharm 2011; 78: 462–469.
42. Kushner J et al. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical agent properties, processing methods, and excipient variability on drug product quality attributes. J Pharm Sci 2014; 103: 527–538.
43. Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol 2013; 238: 169–175.
44. McCormick D. Evolutions in direct compression. Pharm Technol. 2005. Available from http://images.alfresco.advanstar.com/alfresco_images/pharma/2014/08/22/ef1aff6d-1dbf-44f1-86c2-2bfafaf053ff/article-155374.pdfAccessed 25 Apr 2013.
45. Zhang JY, Ternik N. Development of low-dose solid oral tablets using direct compression. In: Zhang JY, ed. Formulation and analytical development for low dose oral drug products. New Jersey: John Wiley & Sons Inc, 2009: 188.
46. Bhandari B et al. Handbook of food powders: processes and properties, 1st edn. Cambridge: Woodhead, 2013: 457.
47. Kitazawa S et al. Effect of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets. J Pharm Pharmacol 1975; 27: 765–770.
48. Schiermeier S, Schmidt PC. Fast dispersible ibuprofen tablets. Eur J Pharma Sci 2002; 15: 295–305.
49. Pabani RM, Rantoola Z. Application of face-centred central design to optimize compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets. Int J Pharm 2012; 430: 18–25.
50. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005; 22: 11–23.
51. Al-khattawi A, Mohammed AR. Compressed orally disintegrating tablets: excipients evolution and formulation strategies. Expert Opin Drug Deliv 2013; 10: 651–663.
52. Goyanes A et al. Fused-filament 3D printing (3DP) for fabrication of tablets. Int J Pharm 2014; 476: 88–92.
53. Goyanes A et al. 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics. Mol Pharm 2015; 2: 4077–4084.